CPT® Code 81331

SNRPN/UBE3A (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A) (eg, Prader-Willi syndrome and/or Angelman syndrome), methylation analysis

Methylation analysis is a laboratory procedure that focuses on the examination of specific genetic markers associated with certain genetic disorders, particularly Prader-Willi syndrome and Angelman syndrome. This analysis is crucial for identifying uniparental disomy, which refers to the inheritance of two copies of a chromosome from one parent and none from the other. The SNRPN gene, which encodes for small nuclear ribonucleoprotein polypeptide N, is linked to Prader-Willi syndrome, while the UBE3A gene, responsible for ubiquitin protein ligase E3A, is associated with Angelman syndrome. These genetic mutations typically arise from random events during the formation of reproductive cells, such as eggs and sperm, or during the early stages of embryonic development, rather than being inherited in a traditional manner. Prader-Willi syndrome manifests when there is a deletion of a paternal segment from the SNRPN gene located on chromosome 15, or when there is maternal uniparental disomy, where two copies of the mother's chromosome are expressed. The symptoms of this syndrome can be observed from infancy and may include being small for gestational age at birth, underdeveloped genitalia, feeding difficulties characterized by a weak suck or swallow reflex, failure to thrive, a weak cry, and hypotonia or floppy muscle tone. As the child grows, they may develop skeletal abnormalities, such as small hands, and skin irregularities, including bands, stripes, and lines, along with distinctive facial features. A hallmark of Prader-Willi syndrome is the development of an intense, uncontrollable craving for food during childhood, which can lead to chronic overeating, obesity, respiratory complications, insulin resistance, and right-sided heart failure. On the other hand, Angelman syndrome occurs when the maternal copy of the UBE3A gene is either mutated or lost, preventing its activation in the brain, or when there is paternal uniparental disomy, where two copies of the father's chromosome are expressed. This syndrome is characterized by a complex genetic disorder that affects the central nervous system, leading to developmental delays, speech impairments, ataxia, seizures, and microcephaly. Symptoms typically begin within the first year of life and may progress throughout childhood, presenting as hand flapping, hyperactivity, a short attention span, and sleep disturbances. Genetic testing through methylation analysis is indicated for individuals exhibiting symptoms consistent with either Prader-Willi or Angelman syndromes, providing essential information for diagnosis and management.